See Ching Chan
Overview
Explore the profile of See Ching Chan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
2204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Cheung C, Chok K, Lee O, Lo K, Chan S, Lo C
Hepatobiliary Pancreat Dis Int
. 2018 Feb;
17(1):86-87.
PMID: 29428111
No abstract available.
3.
Dai W, Chok K, Cheung T, Chan A, Chan S, Lo C
Hepatobiliary Pancreat Dis Int
. 2017 Aug;
16(4):382-386.
PMID: 28823368
Background: Hepatopancreatoduodenectomy is a complicated and challenging procedure but necessary for curative resection for advanced hepatobiliary malignancies. This retrospective study was to examine the safety and survival outcomes of hepatopancreatoduodenectomy...
4.
Liu H, Lo C, Yeung O, Li C, Liu X, Qi X, et al.
J Pathol
. 2017 Apr;
242(3):284-296.
PMID: 28378341
Acute-phase inflammation plays a critical role in liver graft injury. Inflammasomes, multi-molecular complexes in the cytoplasm, are responsible for initiating inflammation. Here, we aimed to explore the role of inflammasomes...
5.
Koh P, Chan S
J Nat Sci Biol Med
. 2017 Mar;
8(1):4-10.
PMID: 28250667
Adult-to-adult living donor liver transplantation (LDLT) is widely accepted today with good outcomes and safety reported worldwide for both donor and recipient. Nonetheless, it remained a highly demanding technical and...
6.
Chu K, Chan S, Sin S, Chan A, Chok K, Cheng I, et al.
Hepatol Int
. 2017 Feb;
11(3):300-305.
PMID: 28176203
Background/purpose: Dyslipidemia is common in liver transplant recipients. This retrospective study investigates whether donors play a role. Methods: Prospectively collected data of donors and recipients of deceased-donor liver transplantation (DDLT)...
7.
Yip V, Cheung T, Poon R, Yau T, Fung J, Dai W, et al.
Transl Gastroenterol Hepatol
. 2017 Feb;
1:51.
PMID: 28138618
Background: Little is known about whether hepatitis B surface antigen (HBsAg) seroconversion (SC) contributes to any survival benefits for patients with hepatocellular carcinoma (HCC). Methods: All patients with hepatitis B-related...
8.
Chok K, Ng K, Cheung T, Chan A, Chan S, Lo C
Hepatobiliary Pancreat Dis Int
. 2017 Jan;
16(1):52-57.
PMID: 28119259
Background: T4 hepatocellular carcinoma (HCC) with invasion to adjacent structure(s) may require resection of not only the tumor but also the invaded structure(s). This study aims to assess whether such...
9.
Chok K, Fung J, Chan A, Dai W, Sharr W, Cheung T, et al.
Ann Surg
. 2016 Dec;
265(1):173-177.
PMID: 28009743
Objective: To evaluate if living donor liver transplantation (LDLT) should be offered to patients with Model for End-stage Liver Disease (MELD) scores ≥35. Background: No data was available to support...
10.
Yap D, Seto W, Fung J, Chok S, Chan S, Chan G, et al.
Dig Liver Dis
. 2016 Nov;
49(2):202-206.
PMID: 27876501
Background: Prediction of hepatorenal syndrome (HRS) remains difficult in advanced cirrhotic patients. Aims: To evaluate use of serum and urine biomarkers to predict HRS. Methods: We prospectively recruited Child's B...